Molecular Pediatric Oncology
11 – 20 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Pam50 intrinsic subtype profiles in primary and metastatic breast cancer show a significant shift toward more aggressive subtypes with prognostic implications
(
- Contribution to journal › Article
-
Mark
Anti-tumor effects of rigosertib in high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Label-free separation of neuroblastoma patient-derived xenograft (PDX) cells from hematopoietic progenitor cell products by acoustophoresis
(
- Contribution to journal › Article
- 2020
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Integrative discovery of treatments for high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
(
- Contribution to journal › Article
-
Mark
Evolution of estrogen receptor status from primary tumors to metastasis and serially collected circulating tumor cells
(
- Contribution to journal › Article
-
Mark
Discovery of epi-enprioline as a novel drug for the treatment of vincristine resistant neuroblastoma
(
- Contribution to journal › Article
-
Mark
Preclinical investigation of novel therapies against neuroblastoma
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
The distribution of circulating tumor cells is different in metastatic lobular compared to ductal carcinoma of the breast –long term prognostic significant
(
- Contribution to journal › Article